IL77166A - Non-reverting salmonella live vaccines - Google Patents

Non-reverting salmonella live vaccines

Info

Publication number
IL77166A
IL77166A IL77166A IL7716685A IL77166A IL 77166 A IL77166 A IL 77166A IL 77166 A IL77166 A IL 77166A IL 7716685 A IL7716685 A IL 7716685A IL 77166 A IL77166 A IL 77166A
Authority
IL
Israel
Prior art keywords
atcc
continuation
deposited
serial
september
Prior art date
Application number
IL77166A
Other languages
English (en)
Other versions
IL77166A0 (en
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24710234&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL77166(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of IL77166A0 publication Critical patent/IL77166A0/xx
Publication of IL77166A publication Critical patent/IL77166A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/879—Salmonella

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL77166A 1984-11-27 1985-11-27 Non-reverting salmonella live vaccines IL77166A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/675,381 US4735801A (en) 1982-09-07 1984-11-27 Novel non-reverting salmonella live vaccines

Publications (2)

Publication Number Publication Date
IL77166A0 IL77166A0 (en) 1986-04-29
IL77166A true IL77166A (en) 1992-02-16

Family

ID=24710234

Family Applications (1)

Application Number Title Priority Date Filing Date
IL77166A IL77166A (en) 1984-11-27 1985-11-27 Non-reverting salmonella live vaccines

Country Status (12)

Country Link
US (1) US4735801A (es)
EP (1) EP0184086B1 (es)
JP (1) JP2610016B2 (es)
AT (1) ATE132901T1 (es)
AU (1) AU584963B2 (es)
CA (1) CA1259934A (es)
DE (1) DE3588076T2 (es)
DK (1) DK174969B1 (es)
ES (1) ES8703525A1 (es)
IE (1) IE72975B1 (es)
IL (1) IL77166A (es)
WO (1) WO1986003123A1 (es)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
US5643771A (en) * 1980-05-19 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Non-reverting live bacterial vaccines
CA1338457C (en) * 1986-08-22 1996-07-16 Henry A. Erlich Purified thermostable enzyme
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5162226A (en) * 1987-08-24 1992-11-10 University Of Tennessee Research Corp. (U.T.R.C.) Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
US5124153A (en) * 1987-08-24 1992-06-23 University Of Tennessee Research Corp. Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
US5112749A (en) * 1987-10-02 1992-05-12 Praxis Biologics, Inc. Vaccines for the malaria circumsporozoite protein
US5811105A (en) * 1987-12-23 1998-09-22 Glaxo Wellcome, Inc. Vaccines containing bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathway
GB8730037D0 (en) * 1987-12-23 1988-02-03 Wellcome Found Vaccines
US6130082A (en) * 1988-05-05 2000-10-10 American Cyanamid Company Recombinant flagellin vaccines
AU637049B2 (en) * 1988-05-05 1993-05-20 American Cyanamid Company Recombinant flagellin vaccines
US5762941A (en) * 1988-07-15 1998-06-09 Institut Pasteur Modified shigella having reduced pathogenicity
US5198346A (en) * 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US5096815A (en) * 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
EP0453452A4 (en) * 1989-01-12 1991-11-21 Commonwealth Scientific And Industrial Research Organization Vaccine
GB8912330D0 (en) * 1989-05-30 1989-07-12 Wellcome Found Live vaccines
IE61635B1 (en) * 1990-03-13 1994-11-16 Trinity College Dublin Improvements in vaccines
GB9007194D0 (en) * 1990-03-30 1990-05-30 Wellcome Found Live vaccines
US5843426A (en) * 1990-12-18 1998-12-01 The General Hospital Corporation Salmonella vaccines
US5695983A (en) * 1990-12-18 1997-12-09 The General Hospital Corporation Salmonella vaccines
TW201794B (es) * 1991-05-03 1993-03-11 American Cyanamid Co
WO1993018165A1 (en) * 1992-03-02 1993-09-16 The Board Of Trustees Of The Leland Stanford Junior University Microorganisms having attenuated invasiveness
WO1994011024A1 (en) * 1992-11-06 1994-05-26 Regents Of The University Of Minnesota Composition protective against p. multocida pasteurellosis infection
DE4333742A1 (de) * 1993-10-04 1995-04-06 Klaus Prof Dr Linde Lebendimpfstoff mit erhöhter Stabilität
AU719411B2 (en) * 1993-11-03 2000-05-11 Zoetis Whc 2 Llc Live in ovo vaccine
JPH07206705A (ja) 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
US6793927B1 (en) * 1993-12-06 2004-09-21 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
US5939075A (en) * 1994-11-04 1999-08-17 The United States Of America As Represented By The Secretary Of The Army Mutants of Brucella melitensis
US6254874B1 (en) 1995-04-13 2001-07-03 President And Fellows Of Harvard College Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same
ATE202484T1 (de) 1995-06-07 2001-07-15 Pfizer In ovo impfung gegen coccidiose
EP0831897B1 (en) * 1995-06-07 2001-03-28 Pfizer Inc. In ovo vaccination against coccidiosis
US5922583A (en) * 1995-10-17 1999-07-13 Biostar Inc. Methods for production of recombinant plasmids
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
ES2286905T3 (es) 1998-12-02 2007-12-01 University Of Maryland, Baltimore Sistema de estabilizacion de plasmidos para el suministro de antigenos.
US6413768B1 (en) 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
US8076130B2 (en) * 1998-12-02 2011-12-13 University Of Maryland, Baltimore Plasmid maintenance system for antigen delivery
US6984378B1 (en) * 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
US6482632B1 (en) 1999-03-29 2002-11-19 Council Of Scientic And Industrial Research Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof
DE69929745T9 (de) * 1999-03-30 2007-02-22 Council Of Scientific And Industrial Research Neuer Bakteriophage, Verfahren zur Isolierung und dafür geeignetes universales Wachstumsmedium
AU780887B2 (en) * 1999-04-09 2005-04-21 Zoetis Services Llc Anti-bacterial vaccine compositions
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
KR20040021678A (ko) 2001-08-30 2004-03-10 엠브렉스, 인코포레이티드 난포낭을 생산하기 위한 개선된 방법
US20050180985A9 (en) * 2001-10-04 2005-08-18 Vladoianu Ion R. Live attenuated salmonella strains for producing monovalent or multivalent vaccines
US20090169568A1 (en) 2004-09-23 2009-07-02 The University Of Melbourne Antigenic Complex for the Diagnosis and Treatment of Porphyromonas Gingivalis Infection
JP2009544279A (ja) * 2006-06-27 2009-12-17 オーラル ヘルス オーストラリア ピーティーワイ リミテッド 歯周病の予防に有用なポルフィロモナス・ジンジバリスポリペプチド
US20100297179A1 (en) 2007-07-12 2010-11-25 Stuart Geoffrey Dashper Immunology Treatment for Biofilms
EP2175851B1 (en) * 2007-07-12 2013-05-15 Oral Health Australia Pty Ltd Biofilm treatment
TWI473626B (zh) 2008-08-29 2015-02-21 Oral Health Australia Pty Ltd 牙齦紫單胞菌（ｐ.ｇｉｎｇｉｖａｌｉｓ）感染之預防、治療及診斷技術
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
MY162557A (en) 2010-02-26 2017-06-15 Oral Health Australia Pty Ltd Treatment or prevention of infection
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US11413819B2 (en) 2020-09-03 2022-08-16 NEXA3D Inc. Multi-material membrane for vat polymerization printer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530275A1 (de) * 1975-07-07 1977-01-27 Max Planck Gesellschaft Salmonella-coli-hybride, verfahren zu deren herstellung und vermehrung und apathogener lebend-impfstoff gegen salmonellosen
DE2843295A1 (de) * 1978-10-04 1980-10-30 Inst Impfstoffe Dessau Verfahren zur herstellung stabiler avirulenter und hochimmunogener bakterienmutanten fuer lebendimpfstoffe
US4336336A (en) * 1979-01-12 1982-06-22 President And Fellows Of Harvard College Fused gene and method of making and using same
US4337314A (en) * 1979-05-23 1982-06-29 Research Corporation Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
US4632830A (en) * 1981-07-31 1986-12-30 The United States Of America As Represented By The Secretary Of The Army Oral vaccine for immunization against enteric disease

Also Published As

Publication number Publication date
EP0184086B1 (en) 1996-01-10
US4735801A (en) 1988-04-05
AU5196686A (en) 1986-06-18
ES8703525A1 (es) 1987-02-16
IE72975B1 (en) 1997-05-07
ES549285A0 (es) 1987-02-16
DK353686A (da) 1986-07-25
IL77166A0 (en) 1986-04-29
EP0184086A2 (en) 1986-06-11
JP2610016B2 (ja) 1997-05-14
DK174969B1 (da) 2004-04-05
CA1259934A (en) 1989-09-26
AU584963B2 (en) 1989-06-08
WO1986003123A1 (en) 1986-06-05
DE3588076D1 (de) 1996-02-22
IE852963L (en) 1986-05-27
JPS62501211A (ja) 1987-05-14
DK353686D0 (da) 1986-07-25
ATE132901T1 (de) 1996-01-15
EP0184086A3 (en) 1987-12-16
DE3588076T2 (de) 1996-05-23

Similar Documents

Publication Publication Date Title
IL77166A0 (en) Non-reverting salmonella live vaccines
EP0368966A4 (en) Novel non-reverting shigella live vaccines
DE69332805T2 (de) Aspertokinasegenvarianten
US5393671A (en) Mutant Escherichia coli capable of enhanced L-glutamic acid production
DE60129877T2 (de) Aminosaüre-herstellende Escherichia Stämme und Verfahren zur Herstellung einer Aminosaüre
EP1792975B1 (en) Microorganism of the genus Corynebacterium having enhanced L-lysine productivity and method of producing L-lysine using said microorganism
HU911440D0 (en) Process for producing polypeptones
EP0600463B1 (en) Process for producing L-tryptophan, L-tyrosine or L-Phenylalanine
CZ285453B6 (cs) DNA, která obsahuje gen kódující aspartokinézu III, mikroorganizmus Escherichia coli a způsob výroby L-threoninu fermentací
ZA934736B (en) Deletion mutants as vaccines for cholera
DE60132277T2 (de) L-Glutaminsäure herstellendes Bacterium und Verfahren zur Herstellung von Glutaminsäure
EP0261627B1 (en) Process for producing l-arginine
EP0556333A4 (en) Avirulent microbes and uses therefor: salmonella typhi.
EP0436886B1 (de) Verfahren zur Herstellung von L-Isoleucin und dafür geeignete Mikroorganismen und rekombinante DNA
EP0204326B1 (en) Process for producing l-threonine and l-isoleucine
AU1028792A (en) Coffee glass & process for producing same
AU3038192A (en) Serpulina hyodysenteriae vaccine
DE3666694D1 (en) Process for producing of 4-(2-methoxyethyl)-phenylglycidyl ether and/or metoprolol
ES2005447A6 (es) Procedimiento de preparacion de una perfeccionada raza mutante de "bordetella bronchiseptica", util para una vacuna atenuada viva destinada a la proteccion contra infeccion de la "b.bronchiseptica".
HUT44288A (en) Process for production of d-(-)-lactid acid
JPS6234392B2 (es)
Plachy Lysine production by auxotrophic-regulatory mutants of Corynebacterium glutamicum.
Plachy et al. Isolation of mutants producing lysine in a medium with molasses.
WO1992001785A1 (de) Verfahren zur herstellung von l-lysin produzierenden mikroorganismen
GB1426448A (en) Process for preparing chloramphenicol analogues

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired